Latest stories on IQV
IQVIA: A Great Business At The Wrong Price (Rating Downgrade)
Seeking Alpha38 · neutralanalyst
IQVIA Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
IQVIA Holdings Earnings Call Highlights Growth, AI Momentum
TipRanks65 · bullishearnings
IQVIA outlines 2026 revenue of $17.275B-$17.475B while raising adjusted EPS to $12.80-$13
Seeking Alpha67 · bullishearnings
IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
IQVIA Holdings Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Stocks making the biggest moves midday: Boeing, Amkor, Corning, Sandisk, Iqvia & more
CNBC50 · neutralgeneral
This Healthcare Stock Is Today's Best in the S&P 500
Barron's67 · bullishearnings
Record R&D Bookings and Cash Flow Support IQVIA’s Upbeat Guidance for 2026
MarketChameleon73 · bullishearnings
ICON plc rises after Anthropic deal, Iqvia earnings
Seeking Alpha67 · bullishearnings
IQVIA surges on Q2 beat and guidance hike
Seeking Alpha68 · bullishearnings
IQVIA raises annual profit forecast on clinical research demand
Reuters71 · bullishearnings
IQVIA Raises 2026 Guidance on Record R&D Bookings and Robust Cash Flow
July 28, 2026
MarketChameleon73 · bullishearnings
IQVIA Non-GAAP EPS of $3.15 beats by $0.12, revenue of $4.37B beats by $70M
Seeking Alpha68 · bullishearnings
IQVIA HOLDINGS INC. (IQV) files 8-K
SEC 8-K50 · neutralgeneral
IQVIA Reports Second-Quarter 2026 Results | IQV Stock News
StockTitan50 · neutralearnings
IQVIA Q2 2026 Earnings Preview
Seeking Alpha55 · neutralearnings
Tracking William Nygren's Harris Associates Portfolio - Q1 2026 Update
Seeking Alpha55 · neutralgeneral
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 | IQV Stock News
StockTitan50 · neutralearnings
Market Update: IQV
Yahoo Finance50 · neutralgeneral
IQVIA Holdings' Q2 2026 Earnings: What to Expect
Barchart56 · neutralearnings
Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why
Yahoo Finance55 · neutralgeneral
Morgan Stanley sees writing on wall for key drug research stocks
The Street54 · neutralanalyst
Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage
Seeking Alpha56 · neutralanalyst